Bioethics Stock Alpha and Beta Analysis

BOTH Stock  USD 0.01  0.00  0.00%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Bioethics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Bioethics over a specified time horizon. Remember, high Bioethics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Bioethics' market risk premium analysis include:
Beta
2.27
Alpha
(1.68)
Risk
12.55
Sharpe Ratio
(0.13)
Expected Return
(1.58)
Please note that although Bioethics alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Bioethics did 1.68  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Bioethics stock's relative risk over its benchmark. Bioethics has a beta of 2.27  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Bioethics will likely underperform. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Bioethics Backtesting, Bioethics Valuation, Bioethics Correlation, Bioethics Hype Analysis, Bioethics Volatility, Bioethics History and analyze Bioethics Performance.

Bioethics Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Bioethics market risk premium is the additional return an investor will receive from holding Bioethics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Bioethics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Bioethics' performance over market.
α-1.68   β2.27

Bioethics expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Bioethics' Buy-and-hold return. Our buy-and-hold chart shows how Bioethics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Bioethics Market Price Analysis

Market price analysis indicators help investors to evaluate how Bioethics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bioethics shares will generate the highest return on investment. By understating and applying Bioethics pink sheet market price indicators, traders can identify Bioethics position entry and exit signals to maximize returns.

Bioethics Return and Market Media

The median price of Bioethics for the period between Sat, Sep 27, 2025 and Fri, Dec 26, 2025 is 1.25 with a coefficient of variation of 85.89. The daily time series for the period is distributed with a sample standard deviation of 0.62, arithmetic mean of 0.72, and mean deviation of 0.61. The Stock did not receive any noticable media coverage during the period.
 Price Growth (%)  
       Timeline  

About Bioethics Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Bioethics or other pink sheets. Alpha measures the amount that position in Bioethics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bioethics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bioethics' short interest history, or implied volatility extrapolated from Bioethics options trading.

Build Portfolio with Bioethics

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Other Information on Investing in Bioethics Pink Sheet

Bioethics financial ratios help investors to determine whether Bioethics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bioethics with respect to the benefits of owning Bioethics security.